Cargando…

The ABCG2 Q141K hyperuricemia and gout associated variant illuminates the physiology of human urate excretion

The pathophysiological nature of the common ABCG2 gout and hyperuricemia associated variant Q141K (rs2231142) remains undefined. Here, we use a human interventional cohort study (ACTRN12615001302549) to understand the physiological role of ABCG2 and find that participants with the Q141K ABCG2 varian...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hoque, Kazi Mirajul, Dixon, Eryn E., Lewis, Raychel M., Allan, Jordyn, Gamble, Gregory D., Phipps-Green, Amanda J., Halperin Kuhns, Victoria L., Horne, Anne M., Stamp, Lisa K., Merriman, Tony R., Dalbeth, Nicola, Woodward, Owen M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7265540/ https://www.ncbi.nlm.nih.gov/pubmed/32488095 http://dx.doi.org/10.1038/s41467-020-16525-w

Ejemplares similares

Influence of the ABCG2 gout risk 141 K allele on urate metabolism during a fructose challenge
por: Dalbeth, Nicola, et al.
Publicado: (2014)

Pleiotropic effect of the ABCG2 gene in gout: involvement in serum urate levels and progression from hyperuricemia to gout
por: Wrigley, Rebekah, et al.
Publicado: (2020)

Body mass index modulates the relationship of sugar-sweetened beverage intake with serum urate concentrations and gout
por: Dalbeth, Nicola, et al.
Publicado: (2015)

Population-specific association between ABCG2 variants and tophaceous disease in people with gout
por: He, Wendy, et al.
Publicado: (2017)

Is repeat serum urate testing superior to a single test to predict incident gout over time?
por: Stewart, Sarah, et al.
Publicado: (2022)

ABCG2 polymorphisms in gout: insights into disease susceptibility and treatment approaches
por: Cleophas, MC, et al.
Publicado: (2017)

Interactions between serum urate-associated genetic variants and sex on gout risk: analysis of the UK Biobank
por: Narang, Ravi K., et al.
Publicado: (2019)

Effect of body mass index on serum urate and renal uric acid handling responses to an oral inosine load: experimental intervention study in healthy volunteers
por: Dalbeth, Nicola, et al.
Publicado: (2020)

The relationship between ferritin and urate levels and risk of gout
por: Fatima, Tahzeeb, et al.
Publicado: (2018)

Longitudinal development of incident gout from low-normal baseline serum urate concentrations: individual participant data analysis
por: Robinson, Philip C., et al.
Publicado: (2021)

The relationship of apolipoprotein B and very low density lipoprotein triglyceride with hyperuricemia and gout
por: Rasheed, Humaira, et al.
Publicado: (2014)

Hyperuricemia in acute gastroenteritis is caused by decreased urate excretion via ABCG2
por: Matsuo, Hirotaka, et al.
Publicado: (2016)

Urate crystal deposition and bone erosion in gout: ‘inside-out’ or ‘outside-in’? A dual-energy computed tomography study
por: Towiwat, Patapong, et al.
Publicado: (2016)

Sugar-sweetened beverage consumption: a risk factor for prevalent gout with SLC2A9 genotype-specific effects on serum urate and risk of gout
por: Batt, Caitlin, et al.
Publicado: (2014)

Familial early-onset hyperuricemia and gout associated with a newly identified dysfunctional variant in urate transporter ABCG2
por: Toyoda, Yu, et al.
Publicado: (2019)

Identification of Two Dysfunctional Variants in the ABCG2 Urate Transporter Associated with Pediatric-Onset of Familial Hyperuricemia and Early-Onset Gout
por: Toyoda, Yu, et al.
Publicado: (2021)

Interaction of the p.Q141K Variant of the ABCG2 Gene with Clinical Data and Cytokine Levels in Primary Hyperuricemia and Gout
por: Horváthová, Veronika, et al.
Publicado: (2019)

The renal urate transporter SLC17A1 locus: confirmation of association with gout
por: Hollis-Moffatt, Jade E, et al.
Publicado: (2012)

ABCG2 dysfunction causes hyperuricemia due to both renal urate underexcretion and renal urate overload
por: Matsuo, Hirotaka, et al.
Publicado: (2014)

Association analysis of the SLC22A11 (organic anion transporter 4) and SLC22A12 (urate transporter 1) urate transporter locus with gout in New Zealand case-control sample sets reveals multiple ancestral-specific effects
por: Flynn, Tanya J, et al.
Publicado: (2013)

The Role of ABCG2 in the Pathogenesis of Primary Hyperuricemia and Gout—An Update
por: Eckenstaler, Robert, et al.
Publicado: (2021)

Genetic polymorphisms and decreased protein expression of ABCG2 urate transporters are associated with susceptibility to gout, disease severity and renal-overload hyperuricemia
por: Pálinkás, Márton, et al.
Publicado: (2022)

The genetics of gout: towards personalised medicine?
por: Dalbeth, Nicola, et al.
Publicado: (2017)

Effects of elevated serum urate on cardiometabolic and kidney function markers in a randomised clinical trial of inosine supplementation
por: Dalbeth, Nicola, et al.
Publicado: (2022)

Gout Remission as a Goal of Urate-Lowering Therapy: A Critical Review
por: Tabi-Amponsah, Adwoa Dansoa, et al.
Publicado: (2023)

Positive association of tomato consumption with serum urate: support for tomato consumption as an anecdotal trigger of gout flares
por: Flynn, Tanya J, et al.
Publicado: (2015)

The impact of genetic variability in urate transporters on oxypurinol pharmacokinetics
por: Hishe, Hailemichael Z., et al.
Publicado: (2022)

An update on the genetic architecture of hyperuricemia and gout
por: Merriman, Tony R
Publicado: (2015)

The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial
por: Becker, Michael A, et al.
Publicado: (2010)

The impact of dysfunctional variants of ABCG2 on hyperuricemia and gout in pediatric-onset patients
por: Stiburkova, Blanka, et al.
Publicado: (2019)

Urate in fingernail represents the deposition of urate burden in gout patients
por: Chen, Haibing, et al.
Publicado: (2020)

Prescription and dosing of urate-lowering therapy, rather than patient behaviours, are the key modifiable factors associated with targeting serum urate in gout
por: Dalbeth, Nicola, et al.
Publicado: (2012)

Molecular Elucidation of a Urate Oxidase from Deinococcus radiodurans for Hyperuricemia and Gout Therapy
por: Chiu, Yi-Chih, et al.
Publicado: (2021)

ABCG2 contributes to the development of gout and hyperuricemia in a genome-wide association study
por: Chen, Chung-Jen, et al.
Publicado: (2018)

Epistatic interaction between PKD2 and ABCG2 influences the pathogenesis of hyperuricemia and gout
por: Dong, Zheng, et al.
Publicado: (2020)

Spatiotemporal gait parameters and plantar pressure distribution during barefoot walking in people with gout and asymptomatic hyperuricemia: comparison with healthy individuals with normal serum urate concentrations
por: Stewart, Sarah, et al.
Publicado: (2016)

Influence of genetic variants on renal uric acid handling in response to frusemide: an acute intervention study
por: Dalbeth, Nicola, et al.
Publicado: (2017)

Interaction of the GCKR and A1CF loci with alcohol consumption to influence the risk of gout
por: Rasheed, Humaira, et al.
Publicado: (2017)

Discovery and characterization of verinurad, a potent and specific inhibitor of URAT1 for the treatment of hyperuricemia and gout
por: Tan, Philip K., et al.
Publicado: (2017)

Alterations in lipidome profiles distinguish early-onset hyperuricemia, gout, and the effect of urate-lowering treatment
por: Kvasnička, Aleš, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_c1u6h4u9jp1lu13jimet5fop72